Overview
Research compounds associated with focus, resilience under cognitive load, neuroprotection signals, and mental-performance support.
6 of 46 published compounds
$20.64
Cognitive & Neuroprotection
focus, mental clarity, brain health, cognitive resilience
Goal hub next step
Build a focus & brain health research path.
Use the quiz before choosing a compound, vendor, or PDF so the route reflects your goal, risk tolerance, and monitoring comfort.
Best options to research first
Ranked by evidence first, then risk. A research starting point, not a clinical recommendation.
Semax
ACTH fragment analogue with preclinical neurotrophic signaling and limited clinical stroke/cognition data.
intranasal
Gene expression changes within hours (animal); clinical stroke outcomes are longer-horizon.
€13.76
3 tracked
Selank
Tuftsin analogue peptide with anxiolytic/nootropic research and limited clinical GAD data.
intranasal
Some rapid responders described in clinical abstracts, but not broad RCT-grade evidence.
€20.64
3 tracked
Cerebrolysin
Porcine neuropeptide mixture used in some international stroke and cognition programs, but not FDA-approved.
intravenous, intramuscular
Clinical outcomes are tracked over days to weeks in stroke or cognition programs.
0 tracked
NSI-189
Investigational neurogenic small molecule often discussed in nootropic circles despite limited human data.
oral
Any central effects would be expected over weeks rather than days.
0 tracked
Humanin
Mitochondrial-derived micropeptide with preclinical cytoprotective and neuroprotective research.
subcutaneous
Model-dependent in preclinical studies.
0 tracked
Lower-risk options
Higher-risk options
No long-term human safety data; explicitly flag this gap.
Trusted vendors for cognitive and neuroprotection research
These vendors currently carry compounds in this goal category. Hub is the trust layer; outbound clicks happen after comparison.
XL Peptides
2 relevant compounds in hub
testing reports on product page
third-party testing reports linked on product page
UK, Europe, and rest of world via vendor shipping options
affiliate: direct product page
Amino Club
2 relevant compounds in hub
product page COA viewer
third-party purity testing; product-level COA on page
US/ROW (verify current policy)
affiliate: public program
Ignite Peptides
2 relevant compounds in hub
COA with order / verify current product report
third-party testing and COA documentation claimed by vendor; verify product-specific report
U.S. domestic territories only
affiliate: direct product page
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.